C─H monofluoroalkylation of pyridines is a highly desirable transformation in medicinal chemistry because the monofluoroalkyl group is known to impart favorable properties to drug candidates, and pyridine rings are prevalent in drug molecules. However, only a few methods have been reported, and they are limited to ortho ‐selective reactions. Herein, we report an unprecedented method for meta ‐selective C─H monofluoroalkylation of pyridines via reactions between difluoroalkyl radicals and dihydropyridines generated in situ. During the reactions, a defluorination/olefin isomerization cascade converts initially formed difluoroalkylated dihydropyridines to monofluoroalkylated pyridines. The method accommodates a broad range of pyridine substrates, as well as other N ‐heteroarenes and fluoroalkylating reagents, and shows promise for late‐stage functionalization of pyridine‐containing drugs.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: